{'fraction_non_alphanumeric': 0.022364217252396165, 'fraction_numerical': 0.010223642172523962, 'mean_word_length': 5.264, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Assessment of the availability of oral drugs for the treatment of type 2 diabetes mellitus in Novosibirsk pharmacies

Introduction. The availability of drugs for the treatment of diabetes mellitus in pharmacies requires special attention and is an important indicator of the quality of pharmaceutical care provided to patients with diabetes mellitus on an outpatient basis. Aim. To assess the availability of oral drugs for the treatment of type 2 diabetes mellitus (T2DM) in Novosibirsk phar¬macies. Materials and methods. The objects of the study were current databases of Novosibirsk pharmacies, data from the State Register of Medicines. The retail availability and affordability of drugs for the treatment of T2DM were assessed. We used the content analysis, statistical method, and comparison method. Results. The retail availability of the majority of drugs for the treatment of T2DM was low. Among the drugs with low availability, the largest part is occupied by combinations of oral hypoglycemic drugs (31.91%). More than half the drugs were unaffordable. The least affordable medications were combinations of oral hypoglycemic drugs (35% of the amount of unaffordable medicial products) and renal glucose reabsorption inhibitors (11.67% of the total amount of unaffordable drugs). Conclusion. The results obtained, which revealed the insufficient retail availability and affordability of oral drugs for the treatment of type 2 diabetes mellitus, may serve as a basis for further research to improve pharmaceutical care for patients with diabetes mellitus.